Guggenheim Reiterates Buy on NextGen Healthcare, Maintains $22 Price Target
Portfolio Pulse from richadhand@benzinga.com
Guggenheim analyst Jack Wallace has reiterated a 'Buy' rating on NextGen Healthcare (NASDAQ:NXGN) and maintained a price target of $22.
July 25, 2023 | 12:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guggenheim analyst has reiterated a 'Buy' rating on NextGen Healthcare and maintained a price target of $22.
The reiteration of a 'Buy' rating by a Guggenheim analyst and the maintenance of a $22 price target indicates a positive outlook for NextGen Healthcare. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100